Higher Crohn's disease rates with vedolizumab: a study

Published Date: 13 Mar 2023

The study results may prompt doctors to choose vedolizumab over anti-TNF therapy as the first-line treatment for Crohn's disease.

Read Full News

Latest News

Can Romiplostim Reduce Chemo Disruptions in GI Cancer?

A recent analysis assesses whether romiplostim can reduce thrombocytopenia-driven chemotherapy dose reductions, delays, and discontinuations.

Tumor Debulking Fails to Boost Survival in Metastatic CRC

Researchers evaluated whether adding tumor debulking to standard palliative systemic therapy improves survival in patients with multiorgan metastatic colorectal cancer in the ORCHESTRA trial.

Analysis-Pediatricians Win Round 1 in Vaccine Fight, but Damage Has Been Done

A federal court injunction on Monday put a check on Health Secretary Robert F. Kennedy Jr.'s rapid assault on U.S. vaccine recommendations, but months of turmoil and...

‘Failure to Thrive’ Now ‘Faltering Weight’ in Pediatrics

The World Health Organization also recommends using a z-score for diagnosing faltering weight, in addition to growth charts.

Tx Delays in CRC More Common in Urban Men, Racial Minorities

A study using data from Surveillance, Epidemiology, and End Results evaluates how sex, race, and geographic disparities affect treatment timeliness in patients with early-onset colorectal cancer.

Popular Caraway Oil for Dyspepsia: Benefit or Risk?

Caraway oil is widely used for digestive symptoms; however, strong clinical evidence supports its use in combination with peppermint oil for functional dyspepsia.

Todays Updates

Therapeutic Drug Monitoring Widely Variable in Ped Rheum

In a survey, pediatric rheumatologists cite a lack of training, lack of data, turnaround time, and lab timing as barriers to broader use.

Treat the Patient, Not the Biomarker: The ctDNA Dilemma

Professor David Kerr warns against 'treating the marker' in CRC. Should rising ctDNA trigger chemo without radiologic proof?

Stress Doesn’t Cause Cancer

The mistaken belief that stress can cause cancer leads many affected individuals to blame themselves for their cancer.

IV Ferumoxytol Beats Oral Iron for Pregnancy Anemia

Intravenous ferumoxytol shows higher efficacy than oral iron in the treatment of anemia in pregnant women, improving hemoglobin at delivery and achieving better anemia resolution.

PRP Injection Improves Female Sexual Function

Platelet-rich plasma injections into the anterior vaginal wall enhance sexual function in premenopausal women.

FDA Seeks New Warning for Certain Parkinson's Drugs

The FDA said on Friday it has notified manufacturers of certain Parkinson's ⁠disease treatments to update their prescribing information with a...

Is ‘Spring Fatigue’ Real? Sleep Study Questions It

In a nine-wave online survey of 418 adults over 18 months, researchers find fatigue levels do not fluctuate seasonally — only everyday activity fatigue falls as days lengthen.

Todays Updates

Therapeutic Drug Monitoring Widely Variable in Ped Rheum

In a survey, pediatric rheumatologists cite a lack of training, lack of data, turnaround time, and lab timing as barriers to broader use.

Treat the Patient, Not the Biomarker: The ctDNA Dilemma

Professor David Kerr warns against 'treating the marker' in CRC. Should rising ctDNA trigger chemo without radiologic proof?

Stress Doesn’t Cause Cancer

The mistaken belief that stress can cause cancer leads many affected individuals to blame themselves for their cancer.

IV Ferumoxytol Beats Oral Iron for Pregnancy Anemia

Intravenous ferumoxytol shows higher efficacy than oral iron in the treatment of anemia in pregnant women, improving hemoglobin at delivery and achieving better anemia resolution.

PRP Injection Improves Female Sexual Function

Platelet-rich plasma injections into the anterior vaginal wall enhance sexual function in premenopausal women.

FDA Seeks New Warning for Certain Parkinson's Drugs

The FDA said on Friday it has notified manufacturers of certain Parkinson's ⁠disease treatments to update their prescribing information with a...

Is ‘Spring Fatigue’ Real? Sleep Study Questions It

In a nine-wave online survey of 418 adults over 18 months, researchers find fatigue levels do not fluctuate seasonally — only everyday activity fatigue falls as days lengthen.

Latest News

A recent analysis assesses whether romiplostim can reduce thrombocytopenia-driven chemotherapy dose reductions, delays, and discontinuations.

Researchers evaluated whether adding tumor debulking to standard palliative systemic therapy improves survival in patients with multiorgan metastatic colorectal cancer in the ORCHESTRA trial.

A federal court injunction on Monday put a check on Health Secretary Robert F. Kennedy Jr.'s rapid assault on U.S. vaccine recommendations, but months of turmoil and...

The World Health Organization also recommends using a z-score for diagnosing faltering weight, in addition to growth charts.

A study using data from Surveillance, Epidemiology, and End Results evaluates how sex, race, and geographic disparities affect treatment timeliness in patients with early-onset colorectal cancer.

Caraway oil is widely used for digestive symptoms; however, strong clinical evidence supports its use in combination with peppermint oil for functional dyspepsia.

News All Time

Rifabutin Regimen Matches Bismuth Regimen in H pylori Rescue

Rifabutin-based triple regimen is noninferior to classical bismuth quadruple regimen as rescue treatment for Helicobacter pylori infection.

Italian Toddler Too Sick for Second Transplant, Doctors Say

An Italian toddler left clinging to life after receiving a damaged donor heart, is not well enough to undergo a second transplant, ⁠a panel of specialists ruled on Wednesday.

Guinea-Bissau Stops Vaccine Study Funded by Trump Administration

Guinea-Bissau's foreign minister has said his government has stopped a study funded by the Trump administration aiming to evaluate side effects of the life-saving hepatitis...

Barrett’s Esophagus Guidance Emphasizes Risk Stratification

Emphasis has shifted to high-quality endoscopy based on patient risk stratification.

Unraveling the Complexities of Concomitant IBD and Hepatobiliary Disease, With Natalia Nedelkopoulou, MD Natalia Nedelkopoulou, MD

Nedelkopoulou emphasizes the importance of structured and multidisciplinary transition programs for young patients with IBD and HPB disease.

Navigating Autoimmune Overlap in Celiac Disease, With Daniel Mallon, MD Daniel Mallon, MD

Mallon explains the shared risks linking celiac disease and type 1 diabetes and why early screening improves outcomes.

Navigating Opportunities and Obstacles in Gastroparesis, With Ronen Arai, MD Ronen Arai, MD

Arai breaks down key recommendations from the 2025 AGA gastroparesis guidelines and what they mean for the field at large.

Fasting-Mimicking Diet Elicits Clinical, Biochemical Response in Mild Crohn’s Disease

Fasting-Mimicking Diet Elicits Clinical, Biochemical Response in Mild Crohn’s Disease

Obefazimod As An “Exciting” Potential Treatment for Ulcerative Colitis, With Bruce Sands, MD Bruce Sands, MD

Sands explains the potential benefits of obefazimod and reviews findings from ABTECT 1 and ABTECT 2 presented at ACG 2025.

Joshua Wechsler, MD, on dupilumab's sustained efficacy in pediatric patients with EoE Joshua Wechsler, MD, MSCI

Dupilumab maintained histologic and endoscopic improvements across all pediatric age groups with EoE, according to Joshua Wechsler, MD.

Julie Khlevner, MD, AGAF, Reacts to the FDA Approval of Linaclotide for Pediatric IBS-C Julie Khlevner, MD, AGAF

Julie Khlevner, MD, AGAF, highlights that FDA approval of linaclotide provides the first pharmacologic therapy for pediatric IBS-C.

NASPGHAN: Best Practices for Celiac Disease Follow-up with Dale Lee, MD Dale Lee, MD

Dale Lee, MD, told HCPLive that regular monitoring and potential psychosocial support are important to help children with celiac disease maintain a gluten-free diet.

ANTHEM-UC: Icotrokinra Shows Sustained Efficacy in Moderate-to-Severe Ulcerative Colitis, With Vipul Jairath, MBChB, DPhil Vipul Jaraith, MBChB, DPhil

ANTHEM-UC study findings presented at ACG show efficacy, durability and safety of icotrokinra in adults with moderate-to-severe ulcerative colitis.

Rimegepant Linked to Increased Rectal Compliance, Reduced Rectal Sensation in IBS, With Ayah Matar, MD Ayah Matar, MD

Late-breaking ACG 2025 data link rimegepant to increased rectal compliance and reduced rectal sensation in IBS without constipation.

Tegoprazan NDA Seeks FDA Approval for 3 GERD Indications

Tegoprazan NDA Seeks FDA Approval for 3 GERD Indications

AGA Urges Caution Around Surgery for Refractory Constipation in Clinical Practice Update

AGA Urges Caution Around Surgery for Refractory Constipation in Clinical Practice Update

Recommended News For You

Novel biomarker has potential for predicting and treating skin cancer metastasis

Losing a reward can affect your motivation and performance.

Updates from the 2022 WHO classification of kidney epithelial tumors

Hair Growth After Cancer; 'Global' Early-Onset CRC; Retifanlimab Boosts OS in NSCLC

Zebrafish models offer fast, effective guidance for personalized therapies for kids with high-risk cancer

Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation

Research discovery halts childhood brain tumor before it forms

Recommended Articles For You

The Ins and Outs of Glossectomy: What You Need to Know  

Seeing Beyond the Pink Ribbon: AI's New Battle Against Breast Cancer 

AI on the Front Lines: Revolutionizing Breast Cancer Detection with Artificial Intelligence 

The Algorithmic Revolution: How AI is Reshaping Precision Oncology from Bench to Bedside 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Adopted cancer cells and the effects of their presence.

2.

The Benefits of Exercise for Substance Use Disorders.

3.

TRK Inhibitor Active in Treatment-Refractory Glioblastoma

4.

Liver cancer cells under pressure: Compression can spark invasion, drug resistance and altered gene activity

5.

Climate change is expected to increase the number of suicide deaths

1.

Integrative Clinical Genomics of Metastatic Cancer: Decoding Tumor Evolution for Precision Oncology

2.

Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025

3.

Unmasking the Hidden Symptoms of Ovarian Cancer

4.

Future of Oncology: Targeted Therapies & Collaborative Innovation Shaping Cancer Care in the USA

5.

Understanding Neutrophilia: Causes, Symptoms, and Treatment Options

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part IV

2.

CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC

3.

Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL

4.

Current Scenario of Cancer- Palliative Care to Close the Care Gap

5.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot